$MRKR Marker Therapeutics, Inc. Insider Trading Week 10/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Marker Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Marker Therapeutics, Inc. in week 10/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 388,800 | 824,256 | 388,800 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 41,200 | 87,344 | 41,200 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 388,800 | 824,256 | 388,800 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 41,200 | 87,344 | 41,200 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Vera Juan | Chief Development O ... | Option Exercise | A | 2.12 | 113,400 | 240,408 | 113,400 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Vera Juan | Chief Development O ... | Option Exercise | A | 2.12 | 26,600 | 56,392 | 26,600 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Szymanska Anna | Vice President, Qua ... | Option Exercise | A | 2.12 | 32,500 | 68,900 | 32,500 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Szymanska Anna | Vice President, Qua ... | Option Exercise | A | 2.12 | 7,500 | 15,900 | 7,500 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Vera Juan | Chief Development O ... | Option Exercise | A | 2.12 | 113,400 | 240,408 | 113,400 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Vera Juan | Chief Development O ... | Option Exercise | A | 2.12 | 26,600 | 56,392 | 26,600 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Szymanska Anna | Vice President, Qua ... | Option Exercise | A | 2.12 | 32,500 | 68,900 | 32,500 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Szymanska Anna | Vice President, Qua ... | Option Exercise | A | 2.12 | 7,500 | 15,900 | 7,500 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Loiacono Michael | Chief Accounting Of ... | Option Exercise | A | 2.12 | 119,100 | 252,492 | 119,100 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Loiacono Michael | Chief Accounting Of ... | Option Exercise | A | 2.12 | 20,900 | 44,308 | 20,900 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Loiacono Michael | Chief Accounting Of ... | Option Exercise | A | 2.12 | 119,100 | 252,492 | 119,100 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Loiacono Michael | Chief Accounting Of ... | Option Exercise | A | 2.12 | 20,900 | 44,308 | 20,900 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Koneru Mythili | Chief Medical Offic ... | Option Exercise | A | 2.12 | 116,100 | 246,132 | 116,100 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Koneru Mythili | Chief Medical Offic ... | Option Exercise | A | 2.12 | 23,900 | 50,668 | 23,900 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Kim Anthony H. | Chief Financial Off ... | Option Exercise | A | 2.12 | 127,500 | 270,300 | 127,500 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Kim Anthony H. | Chief Financial Off ... | Option Exercise | A | 2.12 | 32,500 | 68,900 | 32,500 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Tsvetelina P | VP, Research and De ... | Option Exercise | A | 2.12 | 25,400 | 53,848 | 25,400 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Tsvetelina P | VP, Research and De ... | Option Exercise | A | 2.12 | 14,600 | 30,952 | 14,600 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Garrett Gerald | Vice President, Cli ... | Option Exercise | A | 2.12 | 38,300 | 81,196 | 38,300 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Garrett Gerald | Vice President, Cli ... | Option Exercise | A | 2.12 | 1,700 | 3,604 | 1,700 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Agopyan Nadia | VP, Regulatory Affa ... | Option Exercise | A | 2.12 | 32,700 | 69,324 | 32,700 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Agopyan Nadia | VP, Regulatory Affa ... | Option Exercise | A | 2.12 | 7,300 | 15,476 | 7,300 |